Great reminder on why it matters to KNOW and TRUST who you are working with for your healthcare. GLP1s arent just candy to be handed out - people deserve to be getting actual comprehensive obesity CARE, like what we do at Teladoc Health or my own practice at the University of Utah

*Breaking* Top-line results positive of the highly anticipated #SOUL trial, the first powered CVOT of an oral #GLP1RA 14% reduction in MACE with oral semaglutide among 9,650 people with T2D and established CV disease and/or CKD novonordisk.com/content/nncorp…

Love this reply by Dr Dayspring keeping it real: "speak to your physician and instead of fearing incredibly efficacious and safe statins, fear ASCVD (which statins can safely prevent)"

The benefits of incretin-memetic drugs (IMD) are clear 💉 The benefits of physical activity and nutrition therapy are clear 🏋️‍♂️🥦 This is not an either/or debate. A comprehensive weight management program should include both. Figure Source: doi.org/10.1111/obr.13…

so important for expanded equitable access to cardiometabolic care statnews.com/2024/10/23/med…

this is what scares me about the obesity and diabetes epidemics --- YOUNG people are impacted, which unfortunately means they grow into adults who will spend more years of their lives with complication, illness. jamanetwork.com/journals/jamao…

After a strong start, competition for Novo Nordisk Eli Lilly and Company is coming in the #weightloss space, with widespread innovation to bring options for more people @amgen Roche Altimmune, Inc. Structure Therapeutics Viking Therapeutics Pfizer Inc. Boehringer Ingelheim economist.com/business/2024/… The Economist

#WeightLoss (14% vs 3% placebo + diet/exercise) with #Wegovy improved knee arthritis, STEP-9 published! @nejm article nejm.org/doi/full/10.10…

Headed to ObesityWeek® next week? Get your ballots in now! #OW2024

love Dr Kaplans characterization of obesity care currently as treatment focused — rather than patient focused — arguing that we need to cont working towards comprehensive obesity treatment ObesityWeek® #OW2024

Today is the last day for us to #DoSomething to get Kamala Harris elected! What a remarkable few months this has been — in record time, she’s built an extraordinary campaign, set forth a clear policy agenda, and proven again and again that she will be working not for herself, but

standing room only at Dr. Rami Bailony re real world long term AOM (1st and 2nd gen) vs intensive behav. Interesting findings: short term AOM use <48 weeks not impactful. ‘focus on the relationships’ - AOMs a tool to help people successfully make behav changes #OW2024 ObesityWeek®

Just asked Zeke Emanuel about what we should be doing next for America’s health to have the greatest impact. His answer made me jump out of my chair. Invest in our children. The earlier, the better. Their nutrition, their education, the right early inventions. We can afford it

If MAHA cares about “making Americans healthy” I expect to see: Expansion of Medicare & Medicaid Vaccine requirements for schools Affordable healthcare for ALL Implementing modern agriculture tools for food crops Addressing lies about conventionally-grown foods 1/

Interesting modeling study abt deaths averted with hypothetical increase in GLP1/GIP coverage + uptake - with the key point being: It's not just about weight loss. There's real cardiometabolic health risk that can be improved w incretin therapy. pnas.org/doi/10.1073/pn…

Bright spot for me on today's #WorldDiabetesDay2024 was discussing diabetes and wellbeing w colleagues at Teladoc Health

Sigh. I'm all for improving our food environment, but we can't go back on all the progress that has been made...

🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟 fda.gov/news-events/pr…